21.9.2026, 13:29
Emergen Research, a prominent provider of market research solutions, has announced the launch of its much-awaited suite of comprehensive market research content. This new offering is designed to equip businesses across various industries with actionable insights and data-driven strategies to support growth and long-term success.
Request a free sample copy to understand the complete structure of this report (including summary and table of contents) @https://www.emergenresearch.com/request-...mple/14953
The Cell & Tissue Preservation Market was valued at USD 4.2 billion in 2024 and is projected to reach USD 7.8 billion by 2034, registering a CAGR of 6.4%. This growth trajectory reflects the expanding biotechnology sector, increasing investments in regenerative medicine, and rising demand for biobanking services across pharmaceutical and academic research institutions.
Market revenue growth is driven by factors such as the proliferation of cell therapy clinical trials, expanding tissue engineering applications, and growing emphasis on personalized medicine. According to the World Health Organization, global spending on health research and development reached USD 240 billion in 2023, with significant portions allocated to cell-based therapeutic research. The preservation market benefits directly from this investment surge as researchers require sophisticated preservation technologies to maintain cellular viability during extended storage periods.
Growth is supported by technological advancements in cryopreservation techniques, automated storage systems, and specialized preservation media formulations. The National Institutes of Health reported that over 3,800 cell therapy clinical trials were registered globally in 2023, representing a 23% increase from the previous year. This clinical activity necessitates robust preservation infrastructure to maintain therapeutic cell populations throughout development and commercialization phases.
The market experiences strong demand from biobanking initiatives, which have expanded significantly following increased awareness of precision medicine benefits. The International Society for Biological and Environmental Repositories documented over 1.2 million biospecimens collected globally in 2023, requiring specialized preservation protocols to maintain sample integrity. Academic medical centers and commercial biobanks invest heavily in preservation equipment and consumables to support large-scale specimen repositories.
Growth is underpinned by regulatory frameworks that emphasize quality control and standardization in biological sample management. The Food and Drug Administration's guidance on cell therapy manufacturing requires validated preservation methods, driving adoption of advanced preservation technologies. Additionally, pharmaceutical companies allocate substantial budgets to preservation infrastructure as they develop cell-based therapeutics, with preservation costs representing approximately 15-20% of total cell therapy manufacturing expenses according to industry analyses.
Competitive Landscape
Key players operating in the global cell & tissue preservation market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as technological innovation, capacity expansion, and strategic partnerships are key in propelling market growth. Leading companies focus on developing automated preservation systems, advanced cryoprotectant formulations, and integrated storage solutions that improve efficiency and reduce operational costs for end-users.
Market leaders invest heavily in research and development activities to maintain competitive advantages and address evolving customer requirements. Companies allocate 8-12% of annual revenues to R&D activities, focusing on next-generation preservation technologies including automated monitoring systems, artificial intelligence-powered optimization algorithms, and environmentally sustainable preservation solutions.
Key Global Cell & Tissue Preservation Companies:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- BioLife Solutions Inc.
- Chart Industries Inc.
- Worthington Industries Inc.
- Custom Biogenic Systems
- BioCision LLC
- Sartorius AG
- Corning Incorporated
- Lonza Group AG
At Emergen Research, our mission is to empower businesses with the knowledge and insights needed to make informed decisions and succeed in today’s dynamic market environment. Our research content is crafted to provide professionals and organizations with in-depth analysis, actionable recommendations, and a competitive advantage to support their growth objectives.
Custom requirements can be requested for this report, with customization options available to suit specific business needs @https://www.emergenresearch.com/request-...tion/14953
Key highlights and advantages of the market research content offered by Emergen Research include:
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Request a free sample copy to understand the complete structure of this report (including summary and table of contents) @https://www.emergenresearch.com/request-...mple/14953
The Cell & Tissue Preservation Market was valued at USD 4.2 billion in 2024 and is projected to reach USD 7.8 billion by 2034, registering a CAGR of 6.4%. This growth trajectory reflects the expanding biotechnology sector, increasing investments in regenerative medicine, and rising demand for biobanking services across pharmaceutical and academic research institutions.
Market revenue growth is driven by factors such as the proliferation of cell therapy clinical trials, expanding tissue engineering applications, and growing emphasis on personalized medicine. According to the World Health Organization, global spending on health research and development reached USD 240 billion in 2023, with significant portions allocated to cell-based therapeutic research. The preservation market benefits directly from this investment surge as researchers require sophisticated preservation technologies to maintain cellular viability during extended storage periods.
Growth is supported by technological advancements in cryopreservation techniques, automated storage systems, and specialized preservation media formulations. The National Institutes of Health reported that over 3,800 cell therapy clinical trials were registered globally in 2023, representing a 23% increase from the previous year. This clinical activity necessitates robust preservation infrastructure to maintain therapeutic cell populations throughout development and commercialization phases.
The market experiences strong demand from biobanking initiatives, which have expanded significantly following increased awareness of precision medicine benefits. The International Society for Biological and Environmental Repositories documented over 1.2 million biospecimens collected globally in 2023, requiring specialized preservation protocols to maintain sample integrity. Academic medical centers and commercial biobanks invest heavily in preservation equipment and consumables to support large-scale specimen repositories.
Growth is underpinned by regulatory frameworks that emphasize quality control and standardization in biological sample management. The Food and Drug Administration's guidance on cell therapy manufacturing requires validated preservation methods, driving adoption of advanced preservation technologies. Additionally, pharmaceutical companies allocate substantial budgets to preservation infrastructure as they develop cell-based therapeutics, with preservation costs representing approximately 15-20% of total cell therapy manufacturing expenses according to industry analyses.
Competitive Landscape
Key players operating in the global cell & tissue preservation market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as technological innovation, capacity expansion, and strategic partnerships are key in propelling market growth. Leading companies focus on developing automated preservation systems, advanced cryoprotectant formulations, and integrated storage solutions that improve efficiency and reduce operational costs for end-users.
Market leaders invest heavily in research and development activities to maintain competitive advantages and address evolving customer requirements. Companies allocate 8-12% of annual revenues to R&D activities, focusing on next-generation preservation technologies including automated monitoring systems, artificial intelligence-powered optimization algorithms, and environmentally sustainable preservation solutions.
Key Global Cell & Tissue Preservation Companies:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- BioLife Solutions Inc.
- Chart Industries Inc.
- Worthington Industries Inc.
- Custom Biogenic Systems
- BioCision LLC
- Sartorius AG
- Corning Incorporated
- Lonza Group AG
At Emergen Research, our mission is to empower businesses with the knowledge and insights needed to make informed decisions and succeed in today’s dynamic market environment. Our research content is crafted to provide professionals and organizations with in-depth analysis, actionable recommendations, and a competitive advantage to support their growth objectives.
Custom requirements can be requested for this report, with customization options available to suit specific business needs @https://www.emergenresearch.com/request-...tion/14953
Key highlights and advantages of the market research content offered by Emergen Research include:
- Comprehensive Analysis: Each report is thoroughly researched and delivers an in-depth evaluation of market trends, competitive dynamics, consumer behavior, and emerging opportunities. This enables businesses to uncover untapped markets, develop effective strategies, and make well-informed, data-driven decisions.
- Actionable Recommendations: The content offers practical insights and clear, actionable recommendations to help organizations improve their products, services, and overall customer experience. These suggestions are tailored to specific industry needs, supporting sustainable growth and enhanced profitability.
- Expert Insights: Backed by a team of experienced analysts, Emergen Research provides valuable perspectives on industry challenges, best practices, and upcoming trends, helping businesses stay competitive and capitalize on new opportunities.
- Timely Updates: The research content is consistently updated to reflect the latest market developments. Subscribers gain access to current and relevant insights, allowing them to adapt quickly and remain competitive in a rapidly changing business landscape.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com